Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8.3- Skyepharma PLC

5 Dec 2005 15:08

HBM BioVentures (Cayman) Ltd05 December 2005 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing (Note 1) HBM BIOVENTURES (CAYMAN) LTD Company dealt in SKYEPHARMA PLC Class of relevant securityto which the dealings being disclosed relate (Note 2) ORDINARY SHARES Date of dealing 2 DECEMBER 2005 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 63,780,450 (8.46%)(2) Derivatives (other than options) NA (3) Options and agreements to purchase/sell NA Total 63,780,450 (8.46%) (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5)PURCHASE (02.12.2005) 3,003,923 0.523042SALE N/A N/A (b) Derivatives transactions (other than options) Product name, Long/short Number of securities Price per unit e.g. CFD (Note 6) (Note 7) (Note 5) (c) Options transactions in respect of existing securities(i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, e.g. Expiry Option moneyname, selling, securities price American, date paid/e.g. purchasing, to which European received call varying etc. the option etc. per unit option relates (Note 5) (Note 7) (ii) Exercising Product name, e.g. Number of securities Exercise price per unit call option (Note 5) (d) Other dealings (including new securities)(Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 05 DECEMBER 2005 Contact name JOHN ARNOLD Telephone number +1 345 946 8002 If a connected EFM, name of offeree/offeror with which connected NA If a connected EFM, state nature of connection (Note 10) NA Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
25th Sep 200812:42 pmRNSResult of Bondholders Meeting
24th Sep 20083:24 pmRNSHolding(s) in Company
24th Sep 20083:14 pmRNSHolding(s) in Company
23rd Sep 20086:29 pmRNSHolding(s) in Company
23rd Sep 20086:11 pmRNSHolding(s) in Company
23rd Sep 20083:25 pmRNSRe: Bond Proposals and Open Offer
22nd Sep 200811:09 amRNSVoting Rights and Capital
19th Sep 20084:48 pmRNSSecond Price Monitoring Extn
19th Sep 20084:37 pmRNSPrice Monitoring Extension
19th Sep 200812:39 pmRNSGeneral Meeting Results
18th Sep 20084:41 pmRNSSecond Price Monitoring Extn
18th Sep 20084:36 pmRNSPrice Monitoring Extension
18th Sep 200812:18 pmRNSHolding(s) in Company
18th Sep 200811:43 amRNSHolding(s) in Company
17th Sep 20086:32 pmRNSHolding(s) in Company
17th Sep 200811:49 amRNSHolding(s) in Company
17th Sep 200811:40 amRNSHolding(s) in Company
12th Sep 20089:25 amRNSHolding(s) in Company
4th Sep 200812:23 pmRNSPublication of Prospectus and
4th Sep 200812:09 pmRNSShare Purchase Plan
3rd Sep 20082:09 pmRNSVoting Rights and Capital
2nd Sep 200812:25 pmPRNDisclosure of Short Position - Skyepharma
1st Sep 20086:33 pmRNSBond Consent Solicitation
1st Sep 20086:33 pmRNSPlacing and Open Offer Comple
28th Aug 20087:00 amRNSInterim Results
5th Aug 20084:33 pmRNSShare Purchase Plan
5th Aug 200810:00 amRNSHolding(s) in Company
30th Jul 200812:48 pmRNSHolding(s) in Company
25th Jul 200811:47 amRNSHolding(s) in Company
24th Jul 20084:40 pmRNSSecond Price Monitoring Extn
24th Jul 20084:35 pmRNSPrice Monitoring Extension
22nd Jul 20087:00 amRNSResearch Update
16th Jul 200812:38 pmRNSHolding(s) in Company
9th Jul 20082:40 pmRNSHolding(s) in Company
8th Jul 20087:00 amRNSTrading Update
3rd Jul 20087:00 amRNSResearch Update
2nd Jul 20085:04 pmRNSShare Purchaase Plan
17th Jun 20087:00 amRNSResearch Update
16th Jun 20087:00 amRNSRegulatory Approval
2nd Jun 20085:51 pmRNSShare Purchase Plan
21st May 200812:38 pmRNSAGM Statement
21st May 20087:00 amRNSSuccession Plan
20th May 20087:04 amRNSResearch Update
19th May 20087:00 amRNSInterim Management Statement
2nd May 200810:28 amRNSShare Purchase Plan
30th Apr 20087:00 amRNSResearch Update
24th Apr 200812:04 pmRNSAnnual Information Update
22nd Apr 200810:50 amRNSHolding(s) in Company
22nd Apr 20087:00 amRNSRe Agreement
21st Apr 20084:32 pmRNSAnnual Report and Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.